Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis
Adam Grundhoff, Don Ganem
Adam Grundhoff, Don Ganem
Published January 1, 2004
Citation Information: J Clin Invest. 2004;113(1):124-136. https://doi.org/10.1172/JCI17803.
View: Text | PDF
Article Infectious disease Article has an altmetric score of 1

Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis

  • Text
  • PDF
Abstract

Kaposi sarcoma–associated (KS-associated) herpesvirus (KSHV) infection is linked to the development of both KS and several lymphoproliferative diseases. In all cases, the resulting tumor cells predominantly display latent viral infection. KS tumorigenesis requires ongoing lytic viral replication as well, however, for reasons that are unclear but have been suggested to involve the production of angiogenic or mitogenic factors by lytically infected cells. Here we demonstrate that proliferating cells infected with KSHV in vitro display a marked propensity to segregate latent viral genomes, with only a variable but small subpopulation being capable of stable episome maintenance. Stable maintenance is not due to the enhanced production of viral or host trans-acting factors, but is associated with cis-acting, epigenetic changes in the viral chromosome. These results indicate that acquisition of stable KSHV latency is a multistep process that proceeds with varying degrees of efficiency in different cell types. They also suggest an additional role for lytic replication in sustaining KS tumorigenesis: namely, the recruitment of new cells to latency to replace those that have segregated the viral episome.

Authors

Adam Grundhoff, Don Ganem

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 Total
Citations: 2 5 5 7 11 11 10 14 9 7 6 13 14 13 19 13 11 18 13 9 11 5 226
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (226)

Title and authors Publication Year
Disrupting the OTUD4-USP7 deubiquitinase complex to suppress herpesvirus replication: a novel antiviral strategy
Wang S, Tian X, Zhong Y, Xie X, Gao M, Zhang C, Cheng X, Qi Y, Zhong B, Feng P, Lan K, Zhang J
PLOS Pathogens 2025
Heat shock factor 2 regulates oncogenic gamma-herpesvirus gene expression by remodeling the chromatin at the ORF50 and BZLF1 promoter.
Cutrone L, Djupenström H, Peltonen J, Martinez Klimova E, Corso S, Giordano S, Sistonen L, Gramolelli S
PLoS pathogens 2025
KSHV vIL-6 promotes SIRT3 deacetylation of SERBP1 to inhibit ferroptosis and enhance KSHV-induced cellular transformation by inducing lipoyltransferase 2 mRNA degradation
Jing Zhou, Qin Yan, Tianjiao Wang, Pengjun Wei, Jianhong Liu, Haoran Zhang, Ruoqi Xu, Guochun Chen, Wan Li, Shou-Jiang Gao, Chun Lu
PLoS pathogens 2024
Kaposi's sarcoma herpesvirus exploits the DNA damage response to circularize its genome
Li S, Liu B, Tan M, Juillard F, Szymula A, Álvarez ÁL, Van Sciver N, George A, Ramachandran A, Raina K, Tumuluri VS, Costa CN, Simas JP, Kaye KM
Nucleic Acids Research 2024
RUNX3 inhibits KSHV lytic replication by binding to the viral genome and repressing transcription.
Ren P, Niu D, Chang S, Yu L, Ren J, Ma Y, Lan K
Journal of virology 2024
Virus-modified paraspeckle-like condensates are hubs for viral RNA processing and their formation drives genomic instability
Harper KL, Harrington EM, Hayward C, Anene CA, Wongwiwat W, White RE, Whitehouse A
Nature Communications 2024
FoxK1 and FoxK2 cooperate with ORF45 to promote late lytic replication of Kaposi's sarcoma-associated herpesvirus.
Chen Q, Li X, Quan L, Zhou R, Liu X, Cheng L, Sarid R, Kuang E
Journal of virology 2024
Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
Choe D, Choi D
Frontiers in Oncology 2023
The Kaposi’s sarcoma progenitor enigma: KSHV-induced MEndT-EndMT axis
Naipauer J, Mesri EA
Trends in Molecular Medicine 2023
KSHV infection of endothelial precursor cells with lymphatic characteristics as a novel model for translational Kaposi's sarcoma studies.
Tuohinto K, DiMaio TA, Kiss EA, Laakkonen P, Saharinen P, Karnezis T, Lagunoff M, Ojala PM
PLoS pathogens 2023
Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency.
Broussard G, Ni G, Zhang Z, Li Q, Cano P, Dittmer DP, Damania B
Nature Communications 2023
Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
Damania B, Dittmer DP
Journal of Medical Virology 2023
A Panel of Kaposi’s Sarcoma-Associated Herpesvirus Mutants in the Polycistronic Kaposin Locus for Precise Analysis of Individual Protein Products
M Kleer, G MacNeil, N Adam, E Pringle, J Corcoran, F Goodrum
Journal of virology 2022
Therapeutic Perspectives in the Systemic Treatment of Kaposi's Sarcoma.
Valantin MA, Royston L, Hentzien M, Jary A, Makinson A, Veyri M, Ronot-Bregigeon S, Isnard S, Palich R, Routy JP
Cancers 2022
Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms.
Rusu-Zota G, Manole OM, Galeș C, Porumb-Andrese E, Obadă O, Mocanu CV
2022
PRC1-independent binding and activity of RYBP on the KSHV genome during de novo infection.
Lee SC, Toth Z
PLoS pathogens 2022
The ORF45 Protein of Kaposi’s Sarcoma-Associated Herpesvirus and Its Critical Role in the Viral Life Cycle
Atyeo N, Papp B
Viruses 2022
Epigenetic Reprogramming of Kaposi’s Sarcoma-Associated Herpesvirus during Hypoxic Reactivation
Singh RK, Bose D, Robertson ES
Cancers 2022
Kaposi's sarcoma-associated herpesvirus replication and transcription activator protein activates CD274/PD-L1 gene promoter.
Miyazawa M, Yamamoto Y, Katayama K, Sugimoto Y, Noguchi K
Cancer Science 2022
Kaposi’s sarcoma-associated herpesvirus processivity factor (PF-8) recruits cellular E3 ubiquitin ligase CHFR to promote PARP1 degradation and lytic replication
WC Chung, S Lee, Y Kim, JB Seo, MJ Song, F Zhu
PLoS pathogens 2021
Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi’s Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties
X Kong, D Li, A Mansouri, G Kang, K Sayood, J West, C Wood, JU Jung
Journal of virology 2021
3D culture conditions support Kaposi’s sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells
T Dubich, A Dittrich, K Bousset, R Geffers, G Büsche, M Köster, H Hauser, TF Schulz, D Wirth
Journal of Molecular Medicine 2021
Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma
JC Santiago, JD Goldman, H Zhao, AP Pankow, F Okuku, MW Schmitt, LH Chen, CA Hill, C Casper, WT Phipps, JI Mullins, AV Moses
PLoS pathogens 2021
Targeting the Kaposi’s sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells
CO Haddad, I Kalt, Y Shovman, L Xia, Y Schlesinger, R Sarid, O Parnas
Virology Journal 2021
Identification of UL69 Gene and Protein in Cytomegalovirus-Transformed Human Mammary Epithelial Cells.
Haidar Ahmad S, Al Moussawi F, El Baba R, Nehme Z, Pasquereau S, Kumar A, Molimard C, Monnien F, Algros MP, Karaky R, Stamminger T, Diab Assaf M, Herbein G
Frontiers in Oncology 2021
MLL1 is regulated by KSHV LANA and is important for virus latency.
Tan M, Li S, Juillard F, Chitas R, Custódio TF, Xue H, Szymula A, Sun Q, Liu B, Álvarez ÁL, Chen S, Huang J, Simas JP, McVey CE, Kaye KM
Nucleic Acids Research 2021
Kaposi's Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi's Sarcoma.
Jary A, Veyri M, Gothland A, Leducq V, Calvez V, Marcelin AG
Cancers 2021
Kaposi’s sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis
Chen W, Ding Y, Liu D, Lu Z, Wang Y, Yuan Y
PLoS pathogens 2021
NDRG1 facilitates lytic replication of Kaposi's sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase.
Dong L, Dong J, Xiang M, Lei P, Li Z, Zhang F, Sun X, Niu D, Bai L, Lan K
PLoS pathogens 2021
Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV.
Gam Ze Letova C, Kalt I, Shamay M, Sarid R
International journal of molecular sciences 2021
DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma
AB Eason, SH Sin, M Shah, H Yuan, DJ Phillips, M Droste, A Shamshiev, DP Dittmer, B Kumar
PloS one 2020
Regulation of KSHV Latency and Lytic Reactivation
G Broussard, B Damania
Viruses 2020
The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes Virus
D Choi, E Park, KE Kim, E Jung, YJ Seong, L Zhao, S Madhavan, G Daghlian, HH Lee, PT Daghlian, S Daghlian, K Bui, CJ Koh, AK Wong, IT Cho, YK Hong
Cancer research 2020
Molecular Virology of KSHV in the Lymphocyte Compartment—Insights From Patient Samples and De Novo Infection Models
F Aalam, J Totonchy
Frontiers in Cellular and Infection Microbiology 2020
High-throughput sequencing analysis of a “hit and run” cell and animal model of KSHV tumorigenesis
J Naipauer, D Salyakina, G Journo, S Rosario, S Williams, M Abba, M Shamay, EA Mesri, DP Dittmer
PLoS pathogens 2020
KSHV requires vCyclin to overcome replicative senescence in primary human lymphatic endothelial cells
TA DiMaio, DT Vogt, M Lagunoff, AV Moses
PLoS pathogens 2020
Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease
J Fröhlich, A Grundhoff
Seminars in Immunopathology 2020
Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus Production
S Gramolelli, E Elbasani, K Tuohinto, V Nurminen, T Günther, R Kallinen, S Kaijalainen, R Diaz, A Grundhoff, C Haglund, J Ziegelbauer, T Pellinen, M Bower, M Francois, P Ojala
Cancer research 2020
Host RAB11FIP5 protein inhibits the release of Kaposi's sarcoma-associated herpesvirus particles by promoting lysosomal degradation of ORF45.
Wei X, Dong J, Cheng CC, Ji M, Yu L, Luo S, Wu S, Bai L, Lan K
PLoS pathogens 2020
Epigenetic Regulation of Kaposi's Sarcoma-Associated Herpesvirus Latency.
Campbell M, Yang WS, Yeh WW, Kao CH, Chang PC
Frontiers in microbiology 2020
An Update of the Virion Proteome of Kaposi Sarcoma-Associated Herpesvirus.
Nabiee R, Syed B, Ramirez Castano J, Lalani R, Totonchy JE
Viruses 2020
Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network
W Li, Q Wang, Q Feng, F Wang, Q Yan, SJ Gao, C Lu, PM Lieberman
PLoS pathogens 2019
Kaposi’s Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance
F Juillard, ED Vázquez, M Tan, S Li, KM Kaye, JU Jung
Journal of virology 2019
Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus
G Golas, JD Alonso, Z Toth
Virology 2019
Cancer prevention and control: Kaposi’s sarcoma
J Orem
ecancermedicalscience 2019
Kaposi’s Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis
ES Pringle, CA Robinson, C McCormick, JU Jung
Journal of virology 2019
Association of NFκB and related-cytokines with the viral load and development of antibodies against HHV-8 in people living with HIV/AIDS
JP Gonçales, TR Lopes, VM de Lorena, MR Aciole, JV Júnior, TR Tozetto-Mendoza, PH Braz-Silva, MR Coêlho
Medical Microbiology and Immunology 2019
The Zebrafish Xenograft Platform—A Novel Tool for Modeling KSHV-Associated Diseases
ES Pringle, J Wertman, N Melong, AJ Coombs, AL Young, D OLeary, C Veinotte, CA Robinson, MN Ha, G Dellaire, TE Druley, C McCormick, JN Berman
Viruses 2019
A comparative epigenome analysis of gammaherpesviruses suggests cis-acting sequence features as critical mediators of rapid polycomb recruitment
T Günther, J Fröhlich, C Herrde, S Ohno, L Burkhardt, H Adler, A Grundhoff, ES Robertson
PLoS pathogens 2019
NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.
Wei X, Bai L, Dong L, Liu H, Xing P, Zhou Z, Wu S, Lan K
PLoS pathogens 2019
Control of Viral Latency by Episome Maintenance Proteins.
De Leo A, Calderon A, Lieberman PM
Trends in Microbiology 2019
HIV/AIDS-Associated Viral Oncogenesis
C Meyers
2018
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
JA Bristol, R Djavadian, ER Albright, CB Coleman, M Ohashi, M Hayes, JC Romero-Masters, EA Barlow, PJ Farrell, R Rochford, RF Kalejta, EC Johannsen, SC Kenney, EK Flemington
PLoS pathogens 2018
Mast cell activation and KSHV infection in Kaposi sarcoma
LW Ayers, A Barbachano-Guerrero, SC McAllister, JA Ritchie, E Asiago-Reddy, LC Bartlett, E Cesarman, D Wang, R Rochford, JN Martin, CA King
Clinical cancer research 2018
The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis
A Morales-Sánchez, E Fuentes-Panana
Cancers 2018
Transcriptome Analysis and In Situ Hybridization for FcaGHV1 in Feline Lymphoma
M Aghazadeh, M Shi, P Pesavento, A Durham, T Polley, S Donahoe, R Troyer, V Barrs, E Holmes, J Beatty
Viruses 2018
Role of Pattern Recognition Receptors in KSHV Infection
T Uppal, R Sarkar, R Dhelaria, S Verma
Cancers 2018
Superresolution microscopy reveals structural mechanisms driving the nanoarchitecture of a viral chromatin tether
MJ Grant, MS Loftus, AP Stoja, DH Kedes, MM Smith
Proceedings of the National Academy of Sciences 2018
RNA epitranscriptomics: Regulation of infection of RNA and DNA viruses by N6 -methyladenosine (m 6 A)
B Tan, SJ Gao
Reviews in Medical Virology 2018
Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency
SE Hopcraft, SG Pattenden, LI James, S Frye, DP Dittmer, B Damania, M Lagunoff
PLoS pathogens 2018
Activation and counteraction of antiviral innate immunity by KSHV: an update
X Wei, K Lan
Science Bulletin 2018
Kaposi's Sarcoma-Associated Herpesvirus K8 Is an RNA Binding Protein That Regulates Viral DNA Replication in Coordination with a Noncoding RNA
D Liu, Y Wang, Y Yuan, RM Longnecker
Journal of virology 2018
Nucleolar stress enhances lytic reactivation of the Kaposi's sarcoma-associated herpesvirus
A Gelgor, CG ze Letova, Y Yegorov, I Kalt, R Sarid
Oncotarget 2018
The RNA Epitranscriptome of DNA Viruses
B Tan, SJ Gao, MU Gack
Journal of virology 2018
Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1
M Granato, MG Montani, C Angiolillo, G DOrazi, A Faggioni, M Cirone
Viruses 2018
An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes
C Zhong, M Xu, Y Wang, J Xu, Y Yuan, L Hutt-Fletcher
PLoS pathogens 2017
Reactivation and Lytic Replication of Kaposi’s Sarcoma-Associated Herpesvirus: An Update
Y Yuan, KK Aneja
Frontiers in microbiology 2017
NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency
Z Ma, SE Hopcraft, F Yang, A Petrucelli, H Guo, JP Ting, DP Dittmer, B Damania, P Feng
PLoS pathogens 2017
Kaposi’s sarcoma–associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally
YF Chiu, AU Sugden, K Fox, M Hayes, B Sugden
The Journal of Cell Biology 2017
The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target
B Abere, TM Mamo, S Hartmann, N Samarina, E Hage, J Rückert, SK Hotop, G Büsche, TF Schulz, DP Dittmer
PLoS pathogens 2017
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence
M Weidner-Glunde, G Mariggiò, TF Schulz, MU Gack
Journal of virology 2017
Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy
M Granato, MA Romeo, MS Tiano, R Santarelli, R Gonnella, MS Montani, A Faggioni, M Cirone
Scientific Reports 2017
Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation
EA Caves, RM Butch, SA Cook, LR Wasil, C Chen, YP Di, N Lee, KH Shair, MJ Imperiale
mSphere 2017
Lipids, lipid metabolism and Kaposi’s sarcoma-associated herpesvirus pathogenesis
L Dai, Z Lin, W Jiang, EK Flemington, Z Qin
Virologica Sinica 2017
KSHV-Mediated Angiogenesis in Tumor Progression
P Purushothaman, T Uppal, R Sarkar, S Verma
Viruses 2016
Kaposi’s Sarcoma Herpesvirus Genome Persistence
F Juillard, M Tan, S Li, KM Kaye
Frontiers in microbiology 2016
The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication
Z Zhang, W Chen, MK Sanders, KF Brulois, DP Dittmer, B Damania, RM Longnecker
Journal of virology 2016
KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription
N Gupta, S Thakker, SC Verma
Scientific Reports 2016
Next-Generation Sequencing in the Understanding of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Biology
R Strahan, T Uppal, S Verma
Viruses 2016
Multiple Lytic Origins of Replication Are Required for Optimal Gammaherpesvirus Fitness In Vitro and In Vivo
C Sattler, B Steer, H Adler, PD Ling
PLoS pathogens 2016
Fine-Tuning of the Kaposi’s Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway
S Li, H Hu, Z He, D Liang, R Sun, K Lan, EK Flemington
PLoS pathogens 2016
Recent advances in the study of Kaposi’s sarcoma-associated herpesvirus replication and pathogenesis
D Avey, B Brewers, F Zhu
Virologica Sinica 2015
Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways
X Tan, Y Gao, Y Nan, J Zhang, C Di, X Wang, F Lian, Y Cao, Y Hu, L Xu, H Ma, Y Hong, T Liu, Y Wu, X Xu, Y Yan, L Yang, SJ Gao
PloS one 2015
Activation of DNA Damage Response Pathways during Lytic Replication of KSHV
R Hollingworth, G Skalka, G Stewart, A Hislop, D Blackbourn, R Grand
Viruses 2015
Modulation of DNA Damage and Repair Pathways by Human Tumour Viruses
R Hollingworth, R Grand
Viruses 2015
A Comprehensive Analysis of Replicating Merkel Cell Polyomavirus Genomes Delineates the Viral Transcription Program and Suggests a Role for mcv-miR-M1 in Episomal Persistence
JM Theiss, T Günther, M Alawi, F Neumann, U Tessmer, N Fischer, A Grundhoff, CB Buck
PLoS pathogens 2015
Hsp70 Isoforms Are Essential for the Formation of Kaposi’s Sarcoma-Associated Herpesvirus Replication and Transcription Compartments
B Baquero-Pérez, A Whitehouse, R Sun
PLoS pathogens 2015
Human Herpesvirus 8 Induces Polyfunctional B Lymphocytes That Drive Kaposi's Sarcoma
ER Knowlton, G Rappocciolo, P Piazza, LM Lepone, SV Nadgir, A Bullotta, SJ Berendam, J Li, TA Reinhart, FJ Jenkins, CR Rinaldo
mBio 2014
A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence
ED Vázquez, F Juillard, B Rosner, KM Kaye
Virology 2014
Murine gammaherpesvirus-68 ORF38 encodes a tegument protein and is packaged into virions during secondary envelopment
S Shen, H Guo, H Deng
Protein & Cell 2014
Structural proteins of Kaposi’s sarcoma-associated herpesvirus antagonize p53-mediated apoptosis
P Chudasama, A Konrad, R Jochmann, B Lausen, P Holz, E Naschberger, F Neipel, N Britzen-Laurent, M Stürzl
Oncogene 2014
Influence of ND10 Components on Epigenetic Determinants of Early KSHV Latency Establishment
T Günther, S Schreiner, T Dobner, U Tessmer, A Grundhoff, B Chandran
PLoS pathogens 2014
Kaposi’s Sarcoma-Associated Herpesvirus Genome Programming during the Early Stages of Primary Infection of Peripheral Blood Mononuclear Cells
HC Jha, J Lu, SC Verma, S Banerjee, D Mehta, ES Robertson
mBio 2014
Activation of p90 Ribosomal S6 Kinases by ORF45 of Kaposi's Sarcoma-Associated Herpesvirus Is Critical for Optimal Production of Infectious Viruses
B Fu, E Kuang, W Li, D Avey, X Li, Z Turpin, A Valdes, K Brulois, J Myoung, F Zhu, K Frueh
Journal of virology 2014
Variable Episomal Silencing of a Recombinant Herpesvirus Renders Its Encoded GFP an Unreliable Marker of Infection in Primary Cells
TJ Ellison, DH Kedes, SJ Gao
PloS one 2014
Identification of Properties of the Kaposi's Sarcoma-Associated Herpesvirus Latent Origin of Replication That Are Essential for the Efficient Establishment and Maintenance of Intact Plasmids
P Shrestha, B Sugden
Journal of virology 2014
Transcriptome Analysis of Kaposi's Sarcoma-Associated Herpesvirus during De Novo Primary Infection of Human B and Endothelial Cells
P Purushothaman, S Thakker, SC Verma, RM Longnecker
Journal of virology 2014
LANA Binds to Multiple Active Viral and Cellular Promoters and Associates with the H3K4Methyltransferase hSET1 Complex
J Hu, Y Yang, PC Turner, V Jain, LM McIntyre, R Renne, DP Dittmer
PLoS pathogens 2014
Enhanced Response of T Cells from Murine Gammaherpesvirus 68-Infected Mice Lacking the Suppressor of T Cell Receptor Signaling Molecules Sts-1 and Sts-2
B Cieniewicz, N Carpino, LT Krug, DA Leib
PloS one 2014
Kaposi's Sarcoma Associated Herpesvirus Tegument Protein ORF75 Is Essential for Viral Lytic Replication and Plays a Critical Role in the Antagonization of ND10-Instituted Intrinsic Immunity
F Full, D Jungnickl, N Reuter, E Bogner, K Brulois, B Scholz, M Stürzl, J Myoung, JU Jung, T Stamminger, A Ensser, F Zhu
PLoS pathogens 2014
Efficacious Lytic-induction Therapy for Primary Effusion Lymphoma without KSHV Production
Shruti Bhatt, Brittany M. Ashlock, Ngoc L. Toomey, Luis A. Diaz, Enrique A. Mesri, Izidore S. Lossos, Juan Carlos Ramos
Journal of Clinical Investigation 2013
Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus
RP Darst, I Haecker, CE Pardo, R Renne, MP Kladde
Nucleic Acids Research 2013
A Unique Herpesviral Transcriptional Program in KSHV-Infected Lymphatic Endothelial Cells Leads to mTORC1 Activation and Rapamycin Sensitivity
HH Chang, D Ganem
Cell Host & Microbe 2013
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
S Bhatt, BM Ashlock, Y Natkunam, V Sujoy, JR Chapman, JC Ramos, EA Mesri, IS Lossos
Blood 2013
mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis
D Roy, SH Sin, A Lucas, R Venkataramanan, L Wang, A Eason, V Chavakula, IB Hilton, KM Tamburro, B Damania, DP Dittmer
Cancer research 2013
Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence
ED Vázquez, VJ Carey, KM Kaye
Journal of virology 2013
The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1
LY Wong, K Brulois, Z Toth, KS Inn, SH Lee, K O'Brien, H Lee, SJ Gao, E Cesarman, A Ensser, JU Jung
Journal of virology 2013
The chromatin landscape of Kaposi's sarcoma-associated herpesvirus
Z Toth, K Brulois, JU Jung
Viruses 2013
Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells
S Kati, EH Tsao, T Günther, M Weidner-Glunde, T Rothämel, A Grundhoff, P Kellam, TF Schulz
Journal of virology 2013
Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malaria
KL Conant, A Marinelli, JA Kaleeba
Frontiers in microbiology 2013
Infection and transmission dynamics of rKSHV.219 in primary endothelial cells
HC Jeffery, RL Wheat, DJ Blackbourn, GB Nash, LM Butler
Journal of Virological Methods 2013
Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II
B Xu, L Wang, L González-Molleda, Y Wang, J Xu, Y Yuan
Antimicrobial agents and chemotherapy 2013
Tousled-like Kinases Modulate Reactivation of Gammaherpesviruses from Latency
PJ Dillon, SM Gregory, K Tamburro, MK Sanders, GL Johnson, N Raab-Traub, DP Dittmer, B Damania
Cell Host & Microbe 2013
The Inflammatory Kinase MAP4K4 Promotes Reactivation of Kaposi's Sarcoma Herpesvirus and Enhances the Invasiveness of Infected Endothelial Cells
DA Haas, K Bala, G Büsche, M Weidner-Glunde, S Santag, S Kati, S Gramolelli, M Damas, O Dittrich-Breiholz, M Kracht, J Rückert, Z Varga, G Keri, TF Schulz, B Damania
PLoS pathogens 2013
KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts
Z Qin, A Jakymiw, V Findlay, C Parsons
International Journal of Cell Biology 2012
Tegument Proteins of Kaposi’s Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses
N Sathish, X Wang, Y Yuan
Frontiers in microbiology 2012
The Kaposi’s Sarcoma-Associated Herpesvirus ORF57 Protein and Its Multiple Roles in mRNA Biogenesis
BR Jackson, M Noerenberg, A Whitehouse
Frontiers in microbiology 2012
KSHV Rta Promoter Specification and Viral Reactivation
J Guito, DM Lukac
Frontiers in microbiology 2012
Kaposi’s Sarcoma Associated Herpesvirus Entry into Target Cells
S Chakraborty, MV Veettil, B Chandran
Frontiers in microbiology 2012
Potent Antiviral Activity of Topoisomerase I and II Inhibitors against Kaposi's Sarcoma-Associated Herpesvirus
L González-Molleda, Y Wang, Y Yuan
Antimicrobial agents and chemotherapy 2012
Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle
JA Stahl, CR Paden, SS Chavan, V MacLeod, RD Edmondson, SH Speck, JC Forrest
Journal of virology 2012
Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression
HJ Leung, EM Duran, M Kurtoglu, S Andreansky, TJ Lampidis, EA Mesri
Antimicrobial agents and chemotherapy 2012
Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats
P Purushothaman, ME McDowell, J McGuinness, R Salas, SM Rumjahn, SC Verma
Journal of virology 2012
Kaposi's sarcoma-associated herpesvirus G-protein-coupled receptor prevents AU-rich-element-mediated mRNA decay
JA Corcoran, DA Khaperskyy, BP Johnston, CA King, DP Cyr, AV Olsthoorn, C McCormick
Journal of virology 2012
Hsp90 Inhibitors Are Efficacious against Kaposi Sarcoma by Enhancing the Degradation of the Essential Viral Gene LANA, of the Viral Co-Receptor EphA2 as well as Other Client Proteins
W Chen, SH Sin, KW Wen, B Damania, DP Dittmer, SJ Gao
PLoS pathogens 2012
Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200
K Misstear, SA Chanas, SA Rezaee, R Colman, LL Quinn, HM Long, O Goodyear, J M., AD Hislop, DJ Blackbourn
Journal of virology 2012
Cancer Angiogenesis Induced by Kaposi Sarcoma–Associated Herpesvirus Is Mediated by EZH2
M He, W Zhang, T Bakken, M Schutten, Z Toth, JU Jung, P Gill, M Cannon, SJ Gao
Cancer research 2012
Kaposi Sarcoma Herpesvirus (KSHV) vFLIP Induces B-cell Transdifferentiation and Tumorigenesis in Mice
Gianna Ballon, Kang Chen, Rocio Perez, Wayne Tam, Ethel Cesarman
Journal of Clinical Investigation 2011
Evasion and Subversion of Interferon-Mediated Antiviral Immunity by Kaposi's Sarcoma-Associated Herpesvirus: an Overview
N Sathish, Y Yuan
Journal of virology 2011
Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
K Wakeham, EL Webb, I Sebina, L Muhangi, W Miley, WT Johnson, J Ndibazza, AM Elliott, D Whitby, R Newton
Infectious agents and cancer 2011
Rapid and quantitative assessment of KSHV LANA-mediated DNA replication
ED Vázquez, KM Kaye
Archives of Virology 2011
The HIV Protease Inhibitor Nelfinavir Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication In Vitro▿
S Gantt, J Carlsson, M Ikoma, E Gachelet, M Gray, AP Geballe, L Corey, C Casper, M Lagunoff, J Vieira
Antimicrobial agents and chemotherapy 2011
Lysine residues of interferon regulatory factor 7 affect the replication and transcription activator-mediated lytic replication of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8
T Zhang, Y Wang, L Zhang, B Liu, J Xie, C Wood, J Wang
The Journal of general virology 2011
The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency
ME Ballestas, KM Kaye
Future Microbiology 2011
Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment
S Gantt, C Casper
Current Opinion in Infectious Diseases 2011
Coordination of KSHV Latent and Lytic Gene Control by CTCF-Cohesin Mediated Chromosome Conformation
H Kang, A Wiedmer, Y Yuan, E Robertson, PM Lieberman, SH Speck
PLoS pathogens 2011
An Integrated Approach to Elucidate the Intra-Viral and Viral-Cellular Protein Interaction Networks of a Gamma-Herpesvirus
S Lee, L Salwinski, C Zhang, D Chu, C Sampankanpanich, NA Reyes, A Vangeloff, F Xing, X Li, TT Wu, S Sahasrabudhe, H Deng, DJ LaCount, R Sun, R Renne
PLoS pathogens 2011
Rapamycin Blocks Production of KSHV/HHV8: Insights into the Anti-Tumor Activity of an Immunosuppressant Drug
LA Nichols, LA Adang, DH Kedes, M Luftig
PloS one 2011
Infection of Lymphoblastoid Cell Lines by Kaposi's Sarcoma-Associated Herpesvirus: Critical Role of Cell-Associated Virus
J Myoung, D Ganem
Journal of virology 2011
Ex Vivo Bioluminescence Detection of Alcelaphine Herpesvirus 1 Infection during Malignant Catarrhal Fever
B Dewals, F Myster, L Palmeira, L Gillet, M Ackermann, A Vanderplasschen
Journal of virology 2011
The Single RBP-J Site within the LANA Promoter Is Crucial for Establishing Kaposi's Sarcoma-Associated Herpesvirus Latency during Primary Infection
J Lu, SC Verma, Q Cai, ES Robertson
Journal of virology 2011
Replication and Transcription Activator (RTA) of Murine Gammaherpesvirus 68 Binds to an RTA-Responsive Element and Activates the Expression of ORF18
Y Hong, J Qi, D Gong, C Han, H Deng
Journal of virology 2011
Mutation of a C-Terminal Motif Affects Kaposi's Sarcoma-Associated Herpesvirus ORF57 RNA Binding, Nuclear Trafficking, and Multimerization
A Taylor, BR Jackson, M Noerenberg, DJ Hughes, JR Boyne, M Verow, M Harris, A Whitehouse
Journal of virology 2011
A Role for the Internal Repeat of the Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen in the Persistence of an Episomal Viral Genome
KR Alkharsah, TF Schulz
Journal of virology 2011
De Novo Infection of B Cells during Murine Gammaherpesvirus 68 Latency
ML Freeman, CE Burkum, EJ Yager, DL Woodland, MA Blackman
Journal of virology 2011
Restricted Kaposi's Sarcoma (KS) Herpesvirus Transcription in KS Lesions from Patients on Successful Antiretroviral Therapy
DP Dittmer
mBio 2011
KSHV and the pathogenesis of Kaposi’s sarcoma: listening to human biology and medicine
Donald E. Ganem
Journal of Clinical Investigation 2010
Adaptive immunity to the hepatitis C virus
Christopher M Walker
Advances in virus research 2010
Viral Latency and Its Regulation: Lessons from the γ-Herpesviruses
SH Speck, D Ganem
Cell Host & Microbe 2010
Kaposi's sarcoma and its associated herpesvirus
EA Mesri, E Cesarman, C Boshoff
Nature Reviews Cancer 2010
Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV
Z Qin, M DeFee, JS Isaacs, C Parsons
Virology 2010
Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): Role of heparan sulfate, DC-SIGN, integrins and signaling
N Kerur, MV Veettil, N Sharma-Walia, S Sadagopan, V Bottero, AG Paul, B Chandran
Virology 2010
The Epigenetic Landscape of Latent Kaposi Sarcoma-Associated Herpesvirus Genomes
T Günther, A Grundhoff, P Kellam
PLoS pathogens 2010
Upregulation of xCT by KSHV-Encoded microRNAs Facilitates KSHV Dissemination and Persistence in an Environment of Oxidative Stress
Z Qin, E Freitas, R Sullivan, S Mohan, R Bacelieri, D Branch, M Romano, P Kearney, J Oates, K Plaisance, R Renne, J Kaleeba, C Parsons, EA Mesri
PLoS pathogens 2010
An In Vitro System for Studying Murid Herpesvirus-4 Latency and Reactivation
JS May, NJ Bennett, PG Stevenson, MG Masucci
PloS one 2010
Functional Characterization of Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame K8 by Bacterial Artificial Chromosome-Based Mutagenesis
Y Wang, N Sathish, C Hollow, Y Yuan
Journal of virology 2010
Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells
B Chandran
Journal of virology 2010
The Latency-Associated Nuclear Antigen Interacts with MeCP2 and Nucleosomes through Separate Domains
S Matsumura, LM Persson, LY Wong, AC Wilson
Journal of virology 2010
Murine Gammaherpesvirus 68 LANA Is Essential for Virus Reactivation from Splenocytes but Not Long-Term Carriage of Viral Genome
CR Paden, JC Forrest, NJ Moorman, SH Speck
Journal of virology 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Chromatin organization of gammaherpesvirus latent genomes
I Tempera, PM Lieberman
Biochimica et Biophysica Acta 2009
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda
C Johnston, J Orem, F Okuku, M Kalinaki, M Saracino, E Katongole-Mbidde, M Sande, A Ronald, K McAdam, ML Huang, L Drolette, S Selke, A Wald, L Corey, C Casper
PloS one 2009
Pre-Micro RNA Signatures Delineate Stages of Endothelial Cell Transformation in Kaposi Sarcoma
AJ O'Hara, P Chugh, L Wang, EM Netto, E Luz, WJ Harrington, BJ Dezube, B Damania, DP Dittmer, JA Nelson
PLoS pathogens 2009
KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA
F Cheng, M Weidner-Glunde, M Varjosalo, EM Rainio, A Lehtonen, TF Schulz, PJ Koskinen, J Taipale, PM Ojala, K Früh
PLoS pathogens 2009
Kaposi's Sarcoma-Associated Herpesvirus ORF45 Interacts with Kinesin-2 Transporting Viral Capsid-Tegument Complexes along Microtubules
N Sathish, FX Zhu, Y Yuan, M Farzan
PLoS pathogens 2009
Signaling through Toll-Like Receptors Induces Murine Gammaherpesvirus 68 Reactivation In Vivo
LM Gargano, JC Forrest, SH Speck
Journal of virology 2009
Kaposi's Sarcoma-Associated Herpesvirus RTA Promotes Degradation of the Hey1 Repressor Protein through the Ubiquitin Proteasome Pathway
F Gould, SM Harrison, EW Hewitt, A Whitehouse
Journal of virology 2009
Kaposi's Sarcoma-Associated Herpesvirus Utilizes an Actin Polymerization-Dependent Macropinocytic Pathway To Enter Human Dermal Microvascular Endothelial and Human Umbilical Vein Endothelial Cells
H Raghu, N Sharma-Walia, MV Veettil, S Sadagopan, B Chandran
Journal of virology 2009
Kaposi's Sarcoma-Associated Herpesvirus Encodes a Viral Deubiquitinase
CM González, L Wang, B Damania
Journal of virology 2009
Targeted therapy for Kaposi sarcoma.
Sullivan RJ, Pantanowitz L, Dezube BJ
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2009
New approaches to the treatment of human herpesvirus 8-associated disease
C Casper
Reviews in Medical Virology 2008
Valganciclovir for Suppression of Human Herpesvirus–8 Replication: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover Trial
C Casper, EM Krantz, L Corey, SR Kuntz, J Wang, S Selke, S Hamilton, ML Huang, A Wald
The Journal of Infectious Diseases 2008
HIV/AIDS: Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma–Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease
RJ Sullivan, L Pantanowitz, C Casper, J Stebbing, BJ Dezube
Clinical Infectious Diseases 2008
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus
D Lagos, RJ Vart, F Gratrix, SJ Westrop, V Emuss, PP Wong, R Robey, N Imami, M Bower, F Gotch, C Boshoff
Cell Host & Microbe 2008
Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma
DP Dittmer, CJ Hilscher, ML Gulley, EV Yang, M Chen, R Glaser
International Journal of Cancer 2008
Effects of NFκB activation on KSHV latency and lytic reactivation are complex and context-dependent
C Grossmann, D Ganem
Virology 2008
Raman tweezers provide the fingerprint of cells supporting the late stages of KSHV reactivation
OF Dyson, PW Ford, D Chen, YQ Li, SM Akula
Journal of Cellular and Molecular Medicine 2008
Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response:
HQ Nguyen, AS Magaret, MM Kitahata, SE van Rompaey, A Wald, C Casper
AIDS 2008
An Essential Role for the Proximal but Not the Distal Cytoplasmic Tail of Glycoprotein M in Murid Herpesvirus 4 Infection
JS May, CM Smith, MB Gill, PG Stevenson, P Sommer
PloS one 2008
Peripheral Blood Endothelial Progenitors as Potential Reservoirs of Kaposi's Sarcoma-Associated Herpesvirus
SD Bella, A Taddeo, ML Calabrò, L Brambilla, M Bellinvia, E Bergamo, M Clerici, ML Villa, P Sommer
PloS one 2008
Malignant Catarrhal Fever Induced by Alcelaphine herpesvirus 1 Is Associated with Proliferation of CD8+ T Cells Supporting a Latent Infection
B Dewals, C Boudry, F Farnir, PV Drion, A Vanderplasschen, P Stevenson
PloS one 2008
Kaposi's Sarcoma-Associated Herpesvirus Transactivator RTA Promotes Degradation of the Repressors To Regulate Viral Lytic Replication
Z Yang, Z Yan, C Wood
Journal of virology 2008
Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells
VA Morris, AS Punjabi, M Lagunoff
Journal of virology 2008
Virion-Wide Protein Interactions of Kaposi's Sarcoma-Associated Herpesvirus
R Rozen, N Sathish, Y Li, Y Yuan
Journal of virology 2008
Kaposi's Sarcoma-Associated Herpesvirus ori - Lyt -Dependent DNA Replication: Involvement of Host Cellular Factors
Y Wang, H Li, Q Tang, GG Maul, Y Yuan
Journal of virology 2008
SIAH-1 Interacts with the Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORF45 Protein and Promotes Its Ubiquitylation and Proteasomal Degradation
R Abada, T Dreyfuss-Grossman, Y Herman-Bachinsky, H Geva, SR Masa, R Sarid
Journal of virology 2008
Kaposi's Sarcoma-Associated Herpesvirus Induces Sustained Levels of Vascular Endothelial Growth Factors A and C Early during In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications
R Sivakumar, N Sharma-Walia, H Raghu, MV Veettil, S Sadagopan, V Bottero, L Varga, R Levine, B Chandran
Journal of virology 2008
Oral manifestations associated with HIV infection.
Nokta M
Current HIV/AIDS Reports 2008
Humanes Herpesvirus 8 (HHV-8) und Kaposi-Sarkom
C Lebbé
Der Hautarzt 2007
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma
AD Mutlu, LE Cavallin, L Vincent, C Chiozzini, P Eroles, EM Duran, Z Asgari, AT Hooper, KM la Perle, C Hilsher, SJ Gao, DP Dittmer, S Rafii, EA Mesri
Cancer Cell 2007
Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions
D Whitby, VA Marshall, RK Bagni, WJ Miley, TG McCloud, R Hines-Boykin, JJ Goedert, BA Conde, K Nagashima, J Mikovits, DP Dittmer, DJ Newman
International Journal of Cancer 2007
Opposing roles of RNA receptors TLR3 and RIG-I in the inflammatory response to double-stranded RNA in a Kaposi’s sarcoma cell line
AJ Livengood, CC Wu, DA Carson
Cellular Immunology 2007
The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells
L Chen, M Lagunoff
Virology 2007
K13 Blocks KSHV Lytic Replication and Deregulates vIL6 and hIL6 Expression: A Model of Lytic Replication Induced Clonal Selection in Viral Oncogenesis
J Zhao, V Punj, H Matta, L Mazzacurati, S Schamus, Y Yang, T Yang, Y Hong, PM Chaudhary, DY Jin
PloS one 2007
Signaling Cascades Triggered by Bacterial Metabolic End Products during Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
TL Morris, RR Arnold, J Webster-Cyriaque
Journal of virology 2007
Glycoprotein L Disruption Reveals Two Functional Forms of the Murine Gammaherpesvirus 68 Glycoprotein H
L Gillet, JS May, S Colaco, PG Stevenson
Journal of virology 2007
Modulation of Host Gene Expression by the K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus
MM Brinkmann, M Pietrek, O Dittrich-Breiholz, M Kracht, TF Schulz
Journal of virology 2007
Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma–associated herpesvirus
TK Nun, DJ Kroll, NH Oberlies, DD Soejarto, RJ Case, P Piskaut, T Matainaho, C Hilscher, L Wang, DP Dittmer, SJ Gao, B Damania
Molecular cancer therapeutics 2007
Analysis of Viral cis Elements Conferring Kaposi's Sarcoma-Associated Herpesvirus Episome Partitioning and Maintenance
RL Skalsky, J Hu, R Renne
Journal of virology 2007
Lipid Rafts of Primary Endothelial Cells Are Essential for Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8-Induced Phosphatidylinositol 3-Kinase and RhoA-GTPases Critical for Microtubule Dynamics and Nuclear Delivery of Viral DNA but Dispensable for Binding and Entry
H Raghu, N Sharma-Walia, MV Veettil, S Sadagopan, A Caballero, R Sivakumar, L Varga, V Bottero, B Chandran
Journal of virology 2007
Memory Generation and Maintenance of CD8+ T Cell Function during Viral Persistence
Cush SS, Anderson KM, Ravneberg DH, Weslow-Schmidt JL, Flaño E
Journal of immunology (Baltimore, Md. : 1950) 2007
The latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma
Farnaz D. Fakhari, Joseph H. Jeong, Yogita Kanan, Dirk P. Dittmer
Journal of Clinical Investigation 2006
KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice
Christopher H. Parsons, Laura A. Adang, Jon Overdevest, Christine M. O’Connor, J. Robert Taylor, Jr., David Camerini, and Dean H. Kedes
Journal of Clinical Investigation 2006
Antibody-Independent Control of γ-Herpesvirus Latency via B Cell Induction of Anti-Viral T Cell Responses
KB McClellan, S Gangappa, SH Speck, HW Virgin, G McFadden
PLoS pathogens 2006
Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells
HH Krishnan, N Sharma-Walia, DN Streblow, PP Naranatt, B Chandran
Journal of virology 2006
Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In Vivo
FQ An, HM Folarin, N Compitello, J Roth, SL Gerson, KR McCrae, FD Fakhari, DP Dittmer, R Renne
Journal of virology 2006
Functional Characterization of Kaposi's Sarcoma-Associated Herpesvirus ORF45 byBacterial Artificial Chromosome-Based Mutagenesis
FX Zhu, X Li, F Zhou, SJ Gao, Y Yuan
Journal of virology 2006
RhoA-GTPase Facilitates Entry of Kaposi's Sarcoma-Associated Herpesvirus into Adherent Target Cells in a Src-Dependent Manner
MV Veettil, N Sharma-Walia, S Sadagopan, H Raghu, R Sivakumar, PP Naranatt, B Chandran
Journal of virology 2006
Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Induces Chromosomal Instability through Inhibition of p53 Function
H Si, ES Robertson
Journal of virology 2006
Activation of NF-κB by the Latent vFLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus Is Required for the Spindle Shape of Virus-Infected Endothelial Cells and Contributes to Their Proinflammatory Phenotype
C Grossmann, S Podgrabinska, M Skobe, D Ganem
Journal of virology 2006
Immune Regulation of Viral Infection and Vice Versa
HW Virgin
Immunologic Research 2005
Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells
HH Krishnan, N Sharma-Walia, L Zeng, SJ Gao, B Chandran
Journal of virology 2005
Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50)
S Matsumura, Y Fujita, E Gomez, N Tanese, AC Wilson
Journal of virology 2005
Use of a BJAB-derived cell line for isolation of human herpesvirus 8
P Gasperini, M Barbierato, C Martinelli, P Rigotti, F Marchini, G Masserizzi, F Leoncini, L Chieco-Bianchi, TF Schulz, ML Calabrò
Journal of clinical microbiology 2005
Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells
X Cai, S Lu, Z Zhang, CM Gonzalez, B Damania, BR Cullen
Proceedings of the National Academy of Sciences 2005
Virion Proteins of Kaposi's Sarcoma-Associated Herpesvirus
FX Zhu, JM Chong, L Wu, Y Yuan
Journal of virology 2005
Establishment and Maintenance of Kaposi's Sarcoma-Associated Herpesvirus Latency in B Cells
L Chen, M Lagunoff
Journal of virology 2005
Ex Vivo Stimulation of B Cells Latently Infected with Gammaherpesvirus 68 Triggers Reactivation from Latency
JM Moser, JW Upton, KS Gray, SH Speck
Journal of virology 2005
A Surface Groove Essential for Viral Bcl-2 Function During Chronic Infection In Vivo
J Loh, Q Huang, AM Petros, D Nettesheim, LF van Dyk, L Labrada, SH Speck, B Levine, ET Olejniczak, HW Virgin, G McFadden
PLoS pathogens 2005
Kaposi's Sarcoma-Associated Herpesvirus Virion-Induced Transcription Activation of the ORF50 Immediate-Early Promoter
F Lu, L Day, PM Lieberman
Journal of virology 2005
Modulation of Human Herpesvirus 8/Kaposi's Sarcoma-Associated Herpesvirus Replication and Transcription Activator Transactivation by Interferon Regulatory Factor 7
J Wang, J Zhang, L Zhang, W Harrington, JT West, C Wood
Journal of virology 2005
Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection
E Martró, MJ Cannon, SC Dollard, TJ Spira, AS Laney, CY Ou, PE Pellett
Journal of virology 2004
New viruses shake old paradigms
CY Wang, B Sugden
Journal of Clinical Investigation 2004
Transcriptional Activation by the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Is Facilitated by an N-Terminal Chromatin-Binding Motif
LY Wong, GA Matchett, AC Wilson
Journal of virology 2004
Susceptibility of human fetal mesencyhmal stem cells to Kaposi sarcoma-associated herpesvirus
CH Parsons, B Szomju, DH Kedes
Blood 2004
Disruption of Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen Leads to Abortive Episome Persistence
FC Ye, FC Zhou, SM Yoo, JP Xie, PJ Browning, SJ Gao
Journal of virology 2004

← Previous 1 2 3 … 9 10 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Highlighted by 1 platforms
40 readers on Mendeley
1 readers on CiteULike
See more details